The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score -22.93 — distress zone — historically elevated failure riskWatch
- Earnings-manipulation signal · Beneish M -0.26 — flag raised, worth a closer lookWatch
- Earnings quality 22/100 — worth a closer lookWatch
Leadership changes
From HCW Biologics Inc.'s own filings, the day they're filed.
- Gary M. Winer · Directors · departureeff. 2025-06-17
Latest filings
- DEF 14A · Annual proxy (pay & governance)2026-10-01
- 8-K · Company announcement2026-09-24
- 8-K · Company announcement2026-09-10
- 8-K · Company announcement2026-09-08
- 10-Q · Quarterly report2026-08-14
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about HCW Biologics Inc., every answer cited to the official filings🔒
- The Intelligence Brief — added when HCW Biologics Inc.'s brief passes our SEC-figure check🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.